medigraphic.com
ISSN 1405-8871 (Print)

2025, Number 4

<< Back Next >>

Aten Fam 2025; 32 (4)

Central Adiposity Associated with Cardiovascular Risk

Ramírez-Arguelles RVD, Mendoza-López G, Lozada-Hernández J

Language: Spanish
References: 25
Page: 276-282
PDF size: 216.82 Kb.


ABSTRACT

Objective: To evaluate the association between central adiposity and cardiovascular risk in adults aged 40 to 60 years. Methods: An analytical cross-sectional study was conducted. Individuals with Cushing’s syndrome, polycystic ovary syndrome, continuous steroid treatment, primary, secondary, or subclinical hypothyroidism, or a history of cerebrovascular events were excluded. Sample size was calculated using the difference of proportions formula. Cardiovascular risk was assessed using Euro SCORE II, classifying participants into two groups: ›10 points, high risk; ‹10 points, low risk. Inferential statistics were performed using χ2 and multiple logistic regression, with a significance level of p‹0.05. Results: A total of 300 participants were included, with a median age of 52 years. Females predominated (57.3%). Cardiovascular risk, estimated by the waist-to-height ratio, was present in 55% (n= 165), and by the conicity index as a cardiovascular risk marker in 40.7% (n= 122). The most prevalent comorbidities were type 2 diabetes mellitus (56.3%, OR: 1.6; 95% CI: 0.5–5.1; p= 0.425), hypercholesterolemia (46%, or: 0.7; 95% CI: 0.2–2.3; p= 0.557), adiposity (OR: 5.82; 95% CI: 4.78–7.73), sex (OR: 8.9; 95% CI: 1.9–42), and smoking (OR: 6.2; 95% CI: 1.6–23.6). Conclusions: Central obesity significantly increases cardiovascular risk, even in the absence of comorbidities, and this risk is further amplified in the presence of additional comorbid conditions.


REFERENCES

  1. OPS/OMS. Organización Panamericana de la Salud.Diabetes [Internet]. [Citado 2024 may 27].Disponible en: https://www.paho.org/es/temas/diabetes

  2. World Obesity Federation Global Obesity Observatory[Internet]. [Citado 2024 may 28]. Disponibleen: https://data.worldobesity.org/

  3. Instituto Nacional de Estadística y Geografía(INEGI). Banco de indicadores. Instituto Nacionalde Estadística y Geografía. INEGI; 2021.[Internet]. [Citado 2024 may 28]. Disponible en:https://www.inegi.org.mx/app/indicadores/

  4. Instituto Nacional de Estadística y Geografía(INEGI). Estadística de defunciones registradas.[Internet]. [Citado 2023 jun 10]; Disponible en:https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2023/DR/DR-Ene-jun2022.pdf

  5. Tsao CW, Aday AW, Almarzooq ZI, Alonso A,Beaton AZ, Bittencourt MS, et al. Heart Diseaseand Stroke Statistics-2022 Update: A ReportFrom the American Heart Association. Circulation.2022;145(8):e153–E639.

  6. Picó-Guzmán FJ, Martínez-Montañez OG, Ruelas-Barajas E, Hernández-Ávila M. Estimacióndel impacto económico por complicaciones cardiovascularesy de diabetes mellitus 2019-2028.Rev Med Inst Mex Seguro Soc. 2022;60(Suppl2):S86–S95.

  7. Koh HCE, Mittendorfer B. Adipose tissue lipolysis,plasma fatty acids, and glucose homeostasis inpeople with obesity: New pieces that help solvethe puzzle. EBioMedicine. 2021; 66:103311.

  8. Aragón D, Rivera MF, Lizcano F. Papel de la célulagrasa en el riesgo cardiovascular. Rev ColombCardiol. 2020;27(6):576–581.

  9. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammationand metabolic dysfunction in obesity.Am J Physiol-Cell Physiol. 2021;320(3):C375–C391.

  10. López RM, Nafeh AM, Tamargo BTO, SánchezCJC, López RD, Peña FN, et al. Validación delEuroSCORE II en cirugía de revascularizaciónmiocárdica. CorSalud. 2022;14(2):123–134.

  11. Segura-Fragoso A, Rodríguez-Padial L, Alonso-Moreno FJ, Villarín-Castro A, Rojas-Martelo GA,Rodríguez-Roca GC, et al. Medidas antropométricasde obesidad general y central y capacidad discriminativasobre el riesgo cardiovascular: estudioRICARTO Semergen. 2019;45(5):323–32.

  12. Carranza LBG, Jensen MD, Hartman JJ, JensenTB. Self-Measured vs Professionally MeasuredWaist Circumference. Ann Fam Med.2016;14(3):262–266.

  13. Khan SS, Ning H, Wilkins JT, Allen N, CarnethonM, Berry JD, et al. Association of BodyMass Index With Lifetime Risk of CardiovascularDisease and Compression of Morbidity. JAMACardiol. 2018;3(4):280-287.

  14. Teniente-Valente R, Martínez-Bautista H, Chagolla-Santillán MÁ, Acevedo-Bañuelos I, Romo-Escamilla R, García-Muñoz I, et.al. The usefulnessof the EuroSCORE II model for predicting surgerymortality in a high specialty hospital in México.Cardiovasc Metab Sci. 2023; 34(4):150-158.

  15. Grupo de trabajo de la Guía de Práctica Clínicasobre el manejo de los lípidos como factor de riesgocardiovascular [Internet]. [Citado 2023 junio1]. Disponible en: https://portal.guiasalud.es/gpc/manejo-lipidos-riesgo-cardiovascular/

  16. Andersson C, Johnson AD, Benjamin EJ, Levy D,Vasan RS. 70-year legacy of the Framingham HeartStudy. Nat Rev Cardiol. 2019;16(11):687–698.

  17. Alvero-Cruz JR, Fernández VR, García VMM,García LJA, Rodríguez LMV, Martínez BJ. Sensibilidady especificidad de la adiposidad abdominalcon el síndrome metabólico en ancianos. RevEsp Geriatr Gerontol. 2017;52(3):128-134.

  18. Tekalegn Y, Solomon D, Sahiledengle B, AssefaT, Negash W, Tahir A, et al. Prevalence ofcentral obesity and its associated risk factorsamong adults in Southeast Ethiopia: A community-based cross-sectional study. PLoS One.2022;17(8):e0265107.

  19. Xue R, Li Q, Geng Y, Wang H, Wang F, ZhangS. Abdominal obesity and risk of CVD: a dose–response meta-analysis of thirty-one prospectivestudies. Br J Nutr. 2021;126(9):1420–1430.

  20. Gebremedhin S, Mekonene M, Hagos S, Baye K,Shikur B, Berhane A, et al. Association betweennormal-weight obesity and cardiometabolic riskfactors among adults in Addis Ababa, Ethiopia.Sci Rep. 2023;13(1):22772.

  21. Cao C, Hu H, Zheng X, Zhang X, Wang Y, He Y.Association between central obesity and incidentdiabetes mellitus among Japanese: a retrospectivecohort study using propensity score matching. SciRep. 2022;12(1):13445.

  22. Montenegro MR, Moreno VI, Fontes F, QuintanaH. Prevalence of central obesity accordingto different definitions in normal weight adults oftwo cross-sectional studies in Panama. Lancet RegHealth Am. 2022;10:100215.

  23. Zacarías-Flores M, González-Herrera IV, Sánchez-Rodríguez MA. Riesgo cardiovascular a10 años según la adiposidad central en el envejecimientofemenino. Ginecol Obstet México.2021;89(1):14–23.

  24. Carter JL, Abdullah N, Bragg F, Murad NAA,Taylor H, Fong CS, et al. Body compositionand risk factors for cardiovascular disease inglobal multi-ethnic populations. Int J Obes.2023;47(9):855–864.

  25. Tabary M, Cheraghian B, Mohammadi Z, RahimiZ, Naderian MR, Danehchin L, et al.Association of anthropometric indices withcardiovascular disease risk factors amongadults: a study in Iran. Eur J Cardiovasc Nurs.2021;20(4):358–366.




2020     |     www.medigraphic.com